Nomura Healthcare Fund Class I DLHIX Fund Analysis

| Medalist Rating as of | See Nomura Investment Hub

Morningstar’s Analysis DLHIX

Will DLHIX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

A mixed bag.

Senior Analyst William Samuel Rocco

William Samuel Rocco

Senior Analyst

Summary

Macquarie Healthcare’s pros and cons continue to offset each other, and the strategy retains its Average People and Process ratings.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Sponsor Center